登录 | 注册    微信公众号  
搜索

VEGF-B信息

英文名称:Vascular endothelial growth factor B
中文名称:血管内皮生长因子B
靶点别称:VEGF-related factor,VRF,VEGFB,VEGF-B,VEGFL,Vascular Endothelial Growth Factor B
上市药物数量:1
临床药物数量:2
最高研发阶段:批准上市

VEGF-B产品列表

产品库
物种
标签
属性
货号 物种 产品描述 蛋白结构 纯度 活性
VE6-H5225
Human
Human VEGF-B Protein, His Tag
 
评论(0)
 

VEGF-B 分子别名

VRF,VEGFL,VEGFB,VEGF-B

VEGF-B 分子背景

Vascular endothelial growth factor B (VEGFB) is also known as VEGF-related factor (VRF), is a secreted O-glycosylated protein, which belongs to the PDGF/VEGF growth factor family. VEGFB is expressed in all tissues except liver. Highest levels found in heart, skeletal muscle and pancreas. VEGFB is growth factor for endothelial cells. VEGF-B seems to play a role only in the maintenance of newly formed blood vessels during pathological conditions. VEGF-B also plays an important role on several types of neurons. It is important for the protection of neurons in the retina and the cerebral cortex during stroke and of motoneurons during motor neuron diseases such as amyotrophic lateral sclerosis.VEGF-B167 binds heparin and neuropilin-1 whereas the binding to neuropilin-1 of VEGF-B186 is regulated by proteolysis.

VEGF-B 前沿进展

VEGF-B上市药物信息

英文名称 中文名称 研发代码 研发阶段 公司 最早商品名 最早批准国家 最早适应症 最早批准公司 最早批准日期 适应症 临床试验
Ziv-aflibercept BAY-865321; AVE-0005 批准上市 Regeneron Pharmaceuticals Inc, 赛诺菲 Zaltrap Japan 结直肠癌 Sanofi 2012-08-03 卵巢癌, 实体瘤, 腹水, 肺疾病, 前列腺癌, 结直肠癌, 肺癌, 淋巴瘤, 转移癌 详情

VEGF-B临床药物信息

英文名称 研发代码 研发阶段 公司 适应症 临床试验
CSL-346 2H-10; CSL-346 临床二期 Csl Ltd 二型糖尿病, 糖尿病肾病 详情

消息提示

请输入您的联系方式,再点击提交!

确定